ReferIndia News Bracing for a flood of semaglutide generics, Novo holds the price line

ReferIndia News

Looking for a side income?

Earn on your terms — become a freelancer with us!

Know more
News Image

Bracing for a flood of semaglutide generics, Novo holds the price line

Published on: March 17, 2026, 7:33 p.m. | Source: Business Standard

Generic Semaglutide: Novo Nordisk says competition in semaglutide will be driven by science and quality, not pricing, as multiple generic versions prepare to enter India after patent expiry

Checkout more news
Ad Banner

One Partner for All Your Financial Goals

From financial planning and insurance to portfolio management and retirement solutions—get everything under one trusted roof.

Book Consultation
ReferIndia News contact